Botulinum toxin type A (BTA) has been used in our institution since 2001 in a growing number of patients, which lead to the creation of a specific spasticity treatment clinic. We have 370 patients up to October 2007, which account for a total of 731 treatment sessions. We aimed to evaluate the impact of this treatment on the perspective of the patients treated during 2006, and to make a comparative analysis of ...
Financiadores do RCAAP | |||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |